HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test
Cost: AED 4400.0
Symptoms and Diagnosis
Megalencephalic leukoencephalopathy with subcortical cysts 2A (MLC2A) is a neurological disorder characterized by progressive white matter abnormalities in the brain. This leads to megalencephaly (enlarged brain) and the formation of cysts in the subcortical regions. To diagnose MLC2A, a genetic test called HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test can be conducted.
Test Components
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to conducting the HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with MLC2A.
Test Details
The HEPACAM gene is associated with MLC2A. NGS genetic testing is used to analyze multiple genes simultaneously, allowing for a comprehensive examination of an individual’s genetic makeup. In the case of MLC2A, NGS genetic testing can identify mutations in the HEPACAM gene, which is responsible for causing the disorder. By identifying these mutations, healthcare professionals can accurately diagnose MLC2A, providing crucial information for understanding the underlying cause of the disease and guiding appropriate treatment and management strategies.
Test Name | HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A |
Test Details |
The HEPACAM gene is associated with a neurological disorder called megalencephalic leukoencephalopathy with subcortical cysts 2A (MLC2A). MLC2A is an autosomal recessive disorder characterized by progressive white matter abnormalities in the brain, leading to megalencephaly (enlarged brain) and the formation of cysts in the subcortical regions. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for a comprehensive examination of an individual’s genetic makeup. In the case of MLC2A, NGS genetic testing can be used to identify mutations in the HEPACAM gene, which is responsible for causing the disorder. By identifying mutations in the HEPACAM gene through NGS genetic testing, healthcare professionals can make an accurate diagnosis of MLC2A. This information can be crucial for understanding the underlying cause of the disease and guiding appropriate treatment and management strategies. |